The post-COVID-19 population has a high prevalence of cross-reactive antibodies to spikes from all Orthocoronavirinae genera, 2023, Krammer et al
Discussion in 'Long Covid research' started by EndME, Dec 19, 2023.
Discussion in 'Long Covid research' started by EndME, Dec 19, 2023.